01 1Alps Pharmaceutical Co., Ltd.
02 1Biogate Co., Ltd.
01 1Japanese Pharmacopoeia licorice extract
02 1Liver extract "BG"
01 1Germany
02 1Japan
Japanese Pharmacopoeia Licorice Extract
Registration Number : 217MF11022
Registrant's Address : 2-10-50 Mukaimachi, Furukawa-cho, Hida-shi, Gifu Prefecture
Initial Date of Registration : 2005-12-02
Latest Date of Registration : 2010-04-01
Registration Number : 218MF10596
Registrant's Address : Gifu Prefecture Yamagata City Omori 331-1
Initial Date of Registration : 2006-06-22
Latest Date of Registration : 2006-06-22
A Glycrrhizin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glycrrhizin, including repackagers and relabelers. The FDA regulates Glycrrhizin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glycrrhizin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Glycrrhizin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Glycrrhizin supplier is an individual or a company that provides Glycrrhizin active pharmaceutical ingredient (API) or Glycrrhizin finished formulations upon request. The Glycrrhizin suppliers may include Glycrrhizin API manufacturers, exporters, distributors and traders.
click here to find a list of Glycrrhizin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Glycrrhizin Drug Master File in Japan (Glycrrhizin JDMF) empowers Glycrrhizin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Glycrrhizin JDMF during the approval evaluation for pharmaceutical products. At the time of Glycrrhizin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Glycrrhizin suppliers with JDMF on PharmaCompass.
We have 2 companies offering Glycrrhizin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
